Be very careful with GNBT they sell News. Been hearing about Prostate and breast cancer vaccination for 10years now Phase 2. KEYTRUDA® (pembrolizumab) Is nothing new from Merck. they will license anyone to play with it. GNBT strength is NEW news and 1M A/S share's only. Share holders need to ask for conformation about share structure this guys are know for share INCREASE AND STOCK SPLITS. Look at stock split history > If shares are increased to 1B like before ...... RDGL is a better play cancer wise . Testing and diagnostic I leave it to Quest labs for life.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.